SUPRAANTIGEN
Live / Registered — Registered (as of 29 Nov 2022)
What this means for you
Registered since 29 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88636138
- Registration number
- 6909261
- Mark type
- Stylized text
- Filed
- 30 Sept 2019
- Published for opposition
- 14 Sept 2021
- Registered
- 29 Nov 2022
- Attorney of record
- Kristina Montanaro Schrader
Goods and services
- Class 001 — Chemicals: Chemicals for use in industry and science; chemical substances, chemical materials and chemical preparations, and natural elements, namely, chemical preparations for industrial and scientific purposes, other than for medical or veterinary use; chemical, biochemical, biological and biotechnological preparations for use in industry and science; protein, protein fragments, amino acids, antibodies and fragments thereof for industrial, scientific or research purposes, other than for medical or veterinary use; chemical preparations comprising small molecules for use in industry and science; molecular libraries, comprising libraries of chemical preparations for use in industry and science; small molecule library, comprising libraries of chemical preparations for use in industry and science; antibody library, comprising libraries of antibodies for scientific or research use; reagents for use in the development of antibodies, proteins for binding or detecting antibodies and antibody-producing hybridoma cells for scientific or research purposes or for industrial use; detectably labelled compound for industrial, scientific purposes; diagnostic reagents for industrial, scientific or research purposes; immunological reagents for industrial, scientific or research purposes; biological cell, biological tissue culture for use in non-medical research laboratories; diagnostic tools in the nature of preparations, companion diagnostic agents, biomarkers, imaging agents, PET-Imaging compounds for industrial, scientific purposes other than for medical or veterinary use; diagnostic reagents for industrial, scientific or research purposes other than for medical or veterinary use
- Class 005 — Pharmaceuticals: Pharmaceuticals, medical and veterinary preparations for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; diagnostic preparations and materials for medical or veterinary purposes; companion diagnostic agents, biomarkers, imaging agents, PET-Imaging compounds, all for medical purposes; chemical preparations for medical purposes, namely, for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; chemico-pharmaceutical preparation for medical purposes, namely, for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; antibodies, antibody fragments and antibody derivatives for use in disease testing, diagnosis, prevention and treatment for medical purposes; pharmaceutical and medical preparations in the nature of small molecule compounds for medical purposes; PET-Imaging compounds in the nature of diagnostic radiopharmaceutical agents for use in PET imaging; diagnostic preparations in the nature of companion compounds for medical use; pharmaceutical and medical preparations in the nature of biomarkers for medical purposes; vaccines; antigenic peptides for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; pharmaceutical and medical preparations in the nature of protein or protein fragments for medical purposes; diagnostic reagents for medical purposes; diagnostic antibodies for medical purposes
- Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research, analysis and testing and the development of technology in the field of medicine and pharmaceuticals and research activities relating thereto; providing access to a proprietary technology platform containing antibodies, vaccines and small molecules that gives users the ability to obtain information for research purposes; biological research services; chemical research services in the fields of neurodegenerative diseases and inflammatory diseases; medical research services; scientific and medical laboratory services in biotechnology, chemistry, pharmacy, molecular science and immunotherapy; providing medical and scientific research information in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; scientific research, development and consultancy in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; development of test procedures, assays, test reagents, PET-imaging, companion diagnostic biomarkers, antibodies, vaccines and test kits for the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; biological research, namely, screening and selection of pharmaceutical active substances from biological and biotechnological preparations; custom design and development of biological assays; research and development, namely, vaccine and antibody engineering
Owner
- AC Immune SA, Lausanne, CH
- AC Immune SA, Lausanne, CH
- AC Immune SA, Lausanne, CH
Prosecution history
- 29 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 26 Oct 2022 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 10 Oct 2022 — NOTICE OF ALLOWANCE CANCELLED
- 26 Oct 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Oct 2022 — TEAS DELETE 1(B) BASIS RECEIVED
- 11 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 May 2022 — SOU EXTENSION 1 GRANTED
- 09 May 2022 — SOU EXTENSION 1 FILED
- 09 May 2022 — SOU TEAS EXTENSION RECEIVED
- 27 Jan 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Jan 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Jan 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Nov 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Sept 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED